Biobeat
FDA Cleared Cuffless 24-hour Ambulatory Blood Pressure Monitoring
- Business Model
- B2B
- Website
- bio-beat.com
- Last Round
- Series BDec 2025
- Rounds
- 1
About
Medical-grade cuffless blood pressure monitoring using a wireless, non-invasive FDA-cleared chest patch for 24-hour ambulatory blood pressure measurement.
Summary
Biobeat is a Digital Health company based in Israel. Its most recent funding was a Series B round in Dec 2025. Investors include Ally Bridge Group and OrbiMed.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Investors
Similar Companies
R&D company with 4 SBIR/STTR awards from Department of Defense, Department of Health and Human Se...
AI medical technology company using deep learning to assist hospitals with disease screening, dia...
Tyto Care is transforming primary care by putting health in the hands of consumers. The telehealt...
AI-powered medical imaging solutions provider offering diagnostics and smart healthcare tools, in...
Digital orthodontics platform providing fully customized, 3D-printed tooth-moving tools and treat...
Telehealth platform providing personalized health and wellness treatments for men and women, cove...